New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant

In Deusa Cast #54, Marco Fiaschetti advocates for treatment customization and the inclusion of the compounding model in the revision of RDC 327

Proposal aims to regulate the performance of non-profit entities in a controlled experimental environment, using the Regulatory Sandbox model to comply with STJ decision

Norm review may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents dissenting vote

Resumption of Anvisa review and STJ deadline for cultivation define the sector's direction in the first quarter of the year

Adesaf Institute points out unconstitutionality in vetoing workers with criminal history in research areas and requests review of measure

National mobilization seeks to maintain Anvisa's RDC 660/2022 and prevent risks to the continuity of treatments for thousands of patients

Proposal creates a legal framework for production, importation, and self-cultivation; the report included strict security requirements for the medicinal use of cannabis

Unanimous decision from the 3rd Public Law Chamber benefits a woman, the rapporteur cites STJ criteria

Minister Guilherme Boulos meets sector to discuss working group and inclusion of associations in new medicinal cannabis legislation

Meeting at the Planalto, with the presence of Eduardo Suplicy, discusses the recognition of associations and access to treatment

MJSP ceremony formalizes social participation in Conad, integrating Cannab and FACT among the elected members for the new cycle